Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.
暂无分享，去创建一个
A. Bitonti | J. Dumont | L. Valentino | A. Thompson | N. Key | A. Shapiro | M. Ragni | N. Josephson | G. Pierce | A. Luk | Haiyan Jiang | G. Cheng | D. Euwart | R. Peters | J. Powell | J. Goyal | Lian Li | P. Gozzi | K. Tubridy | B. Hallén